May‐Lill Garly

2.2k total citations
39 papers, 1.7k citations indexed

About

May‐Lill Garly is a scholar working on Immunology, Health and Epidemiology. According to data from OpenAlex, May‐Lill Garly has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Immunology, 22 papers in Health and 16 papers in Epidemiology. Recurrent topics in May‐Lill Garly's work include Immune responses and vaccinations (29 papers), Vaccine Coverage and Hesitancy (22 papers) and Virology and Viral Diseases (14 papers). May‐Lill Garly is often cited by papers focused on Immune responses and vaccinations (29 papers), Vaccine Coverage and Hesitancy (22 papers) and Virology and Viral Diseases (14 papers). May‐Lill Garly collaborates with scholars based in Guinea-Bissau, Denmark and Gambia. May‐Lill Garly's co-authors include Peter Aaby, Ida Maria Lisse, Cesário Martins, Carlitos Balé, Hilton Whittle, Henrik Jensen, Amabélia Rodrigues, Per Gustafson, Morten Sodemann and Christine Stabell Benn and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.

In The Last Decade

May‐Lill Garly

38 papers receiving 1.7k citations

Peers

May‐Lill Garly
Cesário Martins Guinea-Bissau
Andreas Andersen Denmark
Muki Shey South Africa
Anthony Hawkridge South Africa
Benjamin M. Kagina South Africa
Ebrima Touray Gambia
Kaushik Banerjee India
Lawrence D. Frenkel United States
W. A. Orenstein United States
Emily Simons United States
Cesário Martins Guinea-Bissau
May‐Lill Garly
Citations per year, relative to May‐Lill Garly May‐Lill Garly (= 1×) peers Cesário Martins

Countries citing papers authored by May‐Lill Garly

Since Specialization
Citations

This map shows the geographic impact of May‐Lill Garly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by May‐Lill Garly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites May‐Lill Garly more than expected).

Fields of papers citing papers by May‐Lill Garly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by May‐Lill Garly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by May‐Lill Garly. The network helps show where May‐Lill Garly may publish in the future.

Co-authorship network of co-authors of May‐Lill Garly

This figure shows the co-authorship network connecting the top 25 collaborators of May‐Lill Garly. A scholar is included among the top collaborators of May‐Lill Garly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with May‐Lill Garly. May‐Lill Garly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corte, Tamera J., Toby M. Maher, Marlies Wijsenbeek, et al.. (2025). ASPIRE Trial in Idiopathic Pulmonary Fibrosis: A Patient Experience-focused Phase 2b Randomized, Double-blind, Placebo-controlled, Multicenter Trial of the Novel Angiotensin II Type 2 Receptor Agonist Buloxibutid. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A2619–A2619.
2.
Poulsen, Lone Hvitfeldt, Bryce A. Kerlin, Giancarlo Castaman, et al.. (2022). Safety and effectiveness of recombinant factor XIII‐A2 in congenital factor XIII deficiency: Real‐world evidence. Research and Practice in Thrombosis and Haemostasis. 6(2). e12628–e12628. 5 indexed citations
3.
Ettingshausen, Carmen Escuriola, Inga Hegemann, Mindy Simpson, et al.. (2019). Favorable pharmacokinetics in hemophilia B for nonacog beta pegol versus recombinant factor IX‐Fc fusion protein: A randomized trial. Research and Practice in Thrombosis and Haemostasis. 3(2). 268–276. 14 indexed citations
4.
Benn, Christine Stabell, Cesário Martins, Ane Bærent Fisker, et al.. (2014). Interaction between neonatal vitamin A supplementation and timing of measles vaccination: A retrospective analysis of three randomized trials from Guinea-Bissau. Vaccine. 32(42). 5468–5474. 9 indexed citations
5.
Martins, Cesário, Christine Stabell Benn, Andreas Andersen, et al.. (2014). A Randomized Trial of a Standard Dose of Edmonston-Zagreb Measles Vaccine Given at 4.5 Months of Age: Effect on Total Hospital Admissions. The Journal of Infectious Diseases. 209(11). 1731–1738. 54 indexed citations
6.
7.
Aaby, Peter, Cesário Martins, May‐Lill Garly, et al.. (2012). The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy. BMJ Open. 2(4). e000761–e000761. 60 indexed citations
8.
Balé, C, May‐Lill Garly, Cesário Martins, et al.. (2011). Risk Factors for Measles in Young Infants in an Urban African Area With High Measles Vaccination Coverage. The Pediatric Infectious Disease Journal. 30(8). 689–693. 7 indexed citations
9.
Martins, Cesário, Carlitos Balé, May‐Lill Garly, et al.. (2009). Girls may have lower levels of maternal measles antibodies and higher risk of subclinical measles infection before the age of measles vaccination. Vaccine. 27(38). 5220–5225. 21 indexed citations
10.
Garly, May‐Lill, Kamilla Danebod, Jens Nielsen, et al.. (2008). Thymus Size at 6 Months of Age and Subsequent Child Mortality. The Journal of Pediatrics. 153(5). 683–688.e3. 47 indexed citations
11.
Valentiner‐Branth, Palle, Michael Perch, Jens Nielsen, et al.. (2006). Community cohort study of Cryptosporidium parvum infections: sex-differential incidences associated with BCG and diptheria–tetanus–pertussis vaccinations. Vaccine. 25(14). 2733–2741. 24 indexed citations
12.
Rodrigues, Amabélia, Thea Kølsen Fischer, Palle Valentiner‐Branth, et al.. (2006). Community cohort study of rotavirus and other enteropathogens: Are routine vaccinations associated with sex-differential incidence rates?. Vaccine. 24(22). 4737–4746. 28 indexed citations
13.
Roth, Adam, Per Gustafson, Anja Poulsen, et al.. (2005). BCG vaccination scar associated with better childhood survival in Guinea-Bissau. International Journal of Epidemiology. 34(3). 540–547. 158 indexed citations
14.
Roth, Adam, Henrik Jensen, May‐Lill Garly, et al.. (2004). Low Birth Weight Infants and Calmette-Guérin Bacillus Vaccination at Birth. The Pediatric Infectious Disease Journal. 23(6). 544–550. 93 indexed citations
15.
Veirum, Jens Erik, Morten Sodemann, Sidu Biai, et al.. (2004). Routine vaccinations associated with divergent effects on female and male mortality at the paediatric ward in Bissau, Guinea-Bissau. Vaccine. 23(9). 1197–1204. 73 indexed citations
16.
Garly, May‐Lill, Carlitos Balé, Kathryn Hedegaard, et al.. (2003). BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. Vaccine. 21(21-22). 2782–2790. 265 indexed citations
17.
Garly, May‐Lill & Peter Aaby. (2002). The challenge of improving the efficacy of measles vaccine. Acta Tropica. 85(1). 1–17. 35 indexed citations
18.
Aaby, Peter, Henrik Jensen, May‐Lill Garly, et al.. (2002). Routine vaccinations and child survival in a war situation with high mortality: effect of gender. Vaccine. 21(1-2). 15–20. 75 indexed citations
19.
20.
Garly, May‐Lill, Eskild Petersen, Court Pedersen, Jens Lundgren, & Jan Gerstoft. (1997). Toxoplasmosis in Danish AIDS Patients. Scandinavian Journal of Infectious Diseases. 29(6). 597–600. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cesário Martins Breakdown of academic impact, for papers by Andreas Andersen Breakdown of academic impact, for papers by Muki Shey Breakdown of academic impact, for papers by Anthony Hawkridge Breakdown of academic impact, for papers by Benjamin M. Kagina Breakdown of academic impact, for papers by Ebrima Touray Breakdown of academic impact, for papers by Kaushik Banerjee Breakdown of academic impact, for papers by Lawrence D. Frenkel Breakdown of academic impact, for papers by W. A. Orenstein Breakdown of academic impact, for papers by Emily Simons
Rankless by CCL
2026